Document is current

Any future updates will be listed below

Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma

Crossref DOI link: https://doi.org/10.1007/s00262-023-03575-4

Published Online: 2023-11-18

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark